Meningitis and meningococcal septicaemia - Extended review av Pollard, A, Faust, SN, Levin, M

Meningitis and meningococcal septicaemia. av Pollard, A, Faust, SN, Levin, M

Ceftriaxone drug alert: no longer for first line use in meningococcal sepsis. av Faust, SN, Pollard, A, Nadel, S, Ninis, N, Levin, M

Emergency management of meningococcal disease: eight years on. av Pollard, A, Nadel, S, Ninis, N, Faust, SN, Levin, M

Paediatric research in the times of COVID-19 av Fleming, PF, Gale, C, Molloy, EJ, Faust, SN, Costeloe, K, Juszczak, E, Roehr, CC

A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pert... av Marlow, R, Kuriyakose, S, Mesaros, N, Han, HH, Tomlinson, R, Faust, SN, Snape, MD, Pollard, AJ, Finn, A

Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one... av Hoschler, K, Andrews, N, Faust, SN, Finn, A, Pollard, A, Snape, M, Walker, W, Zambon, M, Miller, E

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial av Trück, J, Snape, MD, Tatangeli, F, Voysey, M, Yu, L, Faust, SN, Heath, P, Finn, A, Pollard, A

Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function av Martinón-Torres, FL, Bernatowska, E, Shcherbina, A, Esposito, S, Szenborn, L, Marti, MC, Hughes, S, Faust, SN, Yu, LM, D’Agostino, D, Calabresi, M, Toneatto, D, Snape, MD

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage... av Carr, J, Plested, E, Aley, P, Camara, S, Davis, K, MacLennan, JM, Gray, S, Faust, SN, Borrow, R, Christensen, H, Trotter, C, Maiden, MCJ, Finn, A, Snape, MD

Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-... av Faust, SN, Le Roy, M, Pancharoen, C, Weber, MAR, Cathie, K, Behre, U, Bernatoniene, J, Snape, MD, Helm, K, Pech, CE, Henry, O, Baccarini, C, Povey, M, Gillard, P

Antenatal vaccination against Group B streptococcus: Attitudes of pregnant women and healthcare professionals in the UK to participation in clinical trials and routine implementati... av McQuaid, F, Jones, C, Stevens, Z, Meddaugh, G, O'Sullivan, C, Donaldson, B, Hughes, R, Ford, C, Finn, A, Faust, SN, Gbesemete, D, Bedford, H, Hughes, S, Varghese, AS, Heath, PT, Snape, MD

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial. av Snape, MD, Klinger, C, Daniels, E, John, T, Layton, H, Rollinson, L, Pestridge, S, Dymond, S, Galiza, E, Tansey, S, Scott, D, Baker, SA, Jones, T, Yu, L, Gruber, W, Emini, E, Faust, SN, Finn, A, Heath, P, Pollard, A

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants. av Khatami, A, Snape, MD, Ohene-Kena, B, Young, K, Oeser, C, Michaelis, L, Macleod, E, Smee, H, Van Der Meeren, O, Leyssen, M, Caubet, M, Yu, L, Heath, P, Faust, SN, Finn, A, Pollard, A

The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol av McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall H, Marsh J, Estcourt MJ, Ramsay J, Wadia U, Williams PCM, Tjiam MC, Blyth C, Subbarao K, Nicholson S, Faust S.N., Thornton RB, Mckenzie A, Snelling T, Richmond P

Hämta fulltext

Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial av Hodgson, SH, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, RH, Faust, SN, Heath, PT, Pollard, AJ, Emary, KRW, Pollock, KM, Lazarus, R

Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults av Coughlan, L, Sridhar, S, Payne, R, Edmans, E, Milicic, A, Venkatraman, N, Lugonja, B, Clifton, L, Qi, C, McMichael, A, Folegatti, PM, Lawrie, AM, Roberts, R, de Graaf, H, Sukhtankar, P, Faust, SN, Lewis, DJM, Lambe, T, Hill, AVS, Gilbert, SC

Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised,... av Waddington, C, Walker, W, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P, Allen, R, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A, Heath, P, Finn, A, Faust, SN, Snape, MD, Miller, E, Pollard, A

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised,... av Waddington, C, Walker, W, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P, Allen, R, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A, Heath, P, Finn, A, Faust, SN, Snape, MD, Miller, E, Pollard, A

A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage av Laver, JR, Gbesemete, D, Dale, AP, Pounce, ZC, Webb, CN, Roche, EF, Guy, JM, Berreen, G, Belogiannis, K, Hill, AR, Ibrahim, MM, Ahmed, M, Cleary, DW, Pandey, AK, Humphries, HE, Allen, L, de Graaf, H, Maiden, M, Faust, SN, Gorringe, AR, Read, RC